Patent Assignment
Reel/Frame 038539/0266
Assignment of Assignor's Interest
Recorded: 2016-05-10
Pages: 5
Assignors
ENLOW, ELIZABETH
Executed: 2015-11-13
NGUYEN, MINH NGOC
Executed: 2015-11-13
ONG, WINSTON Z.
Executed: 2015-11-13
Assignee
KALA PHARMACEUTICALS, INC.
100 BEAVER STREET, SUITE 201, WALTHAM, MASSACHUSETTS, 02453
Covered Property
(1)
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Oct 1, 2018
From: KALA PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 047172/0481 →
Termination and Release of Security Interest in Patents at Reel and Frame: 047602 / 0480 & 047172 / 0481
May 5, 2021
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: KALA PHARMACEUTICALS, INC
Reel/Frame 056151/0092 →
Security Interest
May 6, 2021
From: KALA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 056168/0602 →
First Amendment to Ip Security Agreement
Dec 22, 2022
From: KALA PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 062205/0883 →
Change of Name
Sep 21, 2023
From: KALA PHARMACEUTICALS, INC.
To: KALA BIO, INC.
Reel/Frame 065017/0488 →